|
Member
|
|
Join Date: Oct 2012
Location: Los Angeles
Posts: 108
|
|
|
Member
Join Date: Oct 2012
Location: Los Angeles
Posts: 108
|
Could this $23 million be better spent ?
With absolutely no available biomarker that accurately measures PD progression, and the clear lack of even anecdotal evidence demonstrating a robust neuroprotective action of isradipine for PD, is this study money well spent ?
|